Merck Animal Health is investing $895 million in a new De Soto facility, which will bring hundreds of jobs to the area. The ...

The State of Kansas announced an $895 million capital expansion project at the Merck Animal Health manufacturing facility in ...

Merck KGaA (MRK: DE) plans to move its investigational lupus drug enpatoran into late-stage development, after new Phase II data showed clinically meaningful improvement in skin manifestations of the ...

The Texas-based, private equity-backed company that bought DVM Power and its busy West Chester switchgear factory plans to ...

A new study is the first phase 3 to show meaningful improvement in both progression-free and overall survival with first-line ...

Epitopea is a transatlantic cancer immunotherapeutics company developing accessible off-the-shelf RNA-based immunotherapies ...

Phase 3 clinical trial of BNC-210 in social anxiety disorder on track for topline readout in Q3 2025α7 nicotinic ...

Ringworm Treatment Market Regional dynamics and emerging markets drive innovation and demand in the global ringworm treatment industry ...

Evaxion aims for at least 2 new deals in 2025 and is, in the meantime, further developing its AI platform to stay ahead of ...

The global Chromatography Accessories & Consumables Market, valued at US$4.79 billion in 2023, is forecasted to grow at a robust CAGR of 7.5% ...

Phase 3 clinical trial of BNC-210 in social anxiety disorder on track for topline readout in Q3 2025a7 nicotinic acetylcholine receptor PAM MK-1167 partnered with Merck ...